Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: FLUID IN HIS HEART; CONGESTIVE HEART FAILURE; COMPLETE LOSS OF VISION IN RIGHT EYE; WORSENING BLURRED VISION IN HIS LEFT EYE; This spontaneous report received from a consumer concerned a 56 year old male. The patient's weight was 135 kilogram (and also reported in range of 135 -140 pounds), and height was 67 inches. Prior to the primary vaccine, the patient was healthy and did not have issues with his heart or any other conditions except for diabetes that was diagnosed in 1995.  The patient received initial covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: 23-AUG-2021) dose was not reported, 1 total, administered on 12-MAR-2021 at left arm for prophylactic vaccination.  On an unspecified date, the patient experienced blurred vision in his left eye and in AUG-2021, the patient experienced a stroke. The patient started stumbling after the stroke and the patient had not regained full mobility. It was reported that patient was having therapy sessions to improve his motor skills (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1822811 expiry: 20-MAR-2022) dose was not reported, 1 total, administered on 17-NOV-2021 for prophylactic vaccination on left arm as booster dose. Concomitant medications included insulin for diabetes.  On an unspecified date in NOV-2021 after receiving booster dose, the patient experienced complete loss of vision in right eye, and worsening blurred vision in his left eye. The patient had to have 2 eye surgeries to his right eye due to the adverse events experienced (dates of surgery: 01-NOV-2021 and 01-DEC-2021). The patient was prescribed prednisolone 1 percentage for the eyes to be used 4 times a day as well as brimonidine 10 mg to be used twice a day (dose number in series 2). On an unspecified date in 2021, the patient started experiencing shortness of breath and breathing issues. The patient went to see a doctor who tested him and ruled out a COVID infection as well as pneumonia. The doctor also did a Computed tomography (CAT) scan which revealed that the patient had fluid in his heart. On 27-DEC-2021, the patient was subsequently diagnosed with congestive heart failure (dose number in series 2). The patient was required to wear a smart watch to monitor his heart rhythm as well as an angiogram which was not yet scheduled. After the angiogram, it was reported that the patient would need to wear a heart monitor. Laboratory data (dates unspecified) included: CAT scan (NR: not provided) fluid in his heart, and Laboratory test (NR: not provided) ruled out COVID infection and pneumonia.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from congestive heart failure, and complete loss of vision in right eye. The outcome of worsening blurred vision in his left eye and fluid in his heart was not reported. This report was serious (Other Medically Important Condition). This case, involving the same patient is linked to 20211266112 (dose number in series 1). This case, from the same reporter is linked to 20211266078.; Sender's Comments: V0-20211267077 - covid-19 vaccine ad26.cov2.s - Congestive heart failure, Complete loss of vision in right eye, Fluid in his heart. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).